Case Control Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. May 21, 2017; 23(19): 3488-3495
Published online May 21, 2017. doi: 10.3748/wjg.v23.i19.3488
Table 4 Odds ratios and 95%CI for esophageal cancer according to molar difference of insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 (subgroup)
Tertile
P value
1 (referent)23
Molar difference< 87.7787.77-108.14> 108.14
Male
No. of case/control15 / 287/223/25
OR (95%CI)10.339 (0.085-1.349)0.044 (0.004-0.527)0.011
OR adjusted (95%CI)10.186 (0.034-1.015)0.022 (0.001-0.319)0.004
≤ 65 years old
No. of case/control11/147/213/27
OR (95%CI)10.260 (0.052-1.300)0.031 (0.025-0.400)0.007
OR adjusted (95%CI)10.226 (0.042-1.224)0.028 (0.002-0.389)0.007